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Cell surface receptors for the Fe domain of IgG are found on most cells of the
hematopoietic lineage andare definedby their ability to bind IgG-antigencomplexes .
This binding couples the humoral and cellular immune response and is a compo-
nent in an organism's capacity to clearforeign antigens . In thehuman, these receptors
havebeen dividedinto three classesbased on differences in apparent molecular mass,
affinity for IgG, cellular distribution and reactivity with mAbs (reviewed in refer-
ence 1) . FcRI is a high affinity Fc receptor, bindingmonomericIgG, and is expressed
onmonocytic cells . FcRs II andIII arelow affinity receptors, binding immunecom-
plexes of IgG, and are expressed on both myeloid and lymphoid cells . The broad
distribution ofFcRII is mirrored in the array ofcellular responses attributed to these
receptors . Crosslinking ofFcRII on monocytes and granulocytes by immune com-
plexes results in effector responses such as phagocytosis, antibody-dependent cel-
lular cytotoxicity (ADCC), ' and the release of mediators of inflammation (2). En-
gagement ofthese receptorson lymphocytes is suggested to be involved in the regulation
of lymphocyte differentiation and antibody production (3).
The structural basis for this functional heterogeneity in response to a common
ligand was first elucidated forthemurine low affinityIgG Fc receptors, murine FcRII.
Twogenes, a and (3, encode this class of receptors anddisplay nearly identical ligand
binding domains coupled to divergent membrane spanning and intracytoplasmic
domains (4-6). a is expressed on macrophages and NK cells (4, 7, 8), while 0 is
expressedon both myeloidand lymphoid cells . Alternative splicing ofa cytoplasmic
exon ofthe a gene is tissue specific, generating further diversity in theintracytoplasmic
domains of these receptors . The implication of thosedata arethat functional hetero-
geneity resultsfrom the divergentmembrane spanningandintracytoplasmic domains .
Analysis ofthehumanhomologues ofthe low affinity IgG Fc receptors lendsaddi-
tional support to this model. In man, two classes of low affinity receptors have been
defined by virtue of their apparent molecular mass, reactivity with mAbs and cel-
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lular distribution (9). FcRII(CD32) is expressed on most myeloid and lymphoid cells,
while FCRIII(CD16) expression is restricted, appearing on NK cells, macrophages,
and neutrophils. Recent studies have demonstrated that FcRIII(CD16) exists in two
alternative membrane anchored forms, which result from tissue specific expression
of two genes differing by single nucleotide substitutions (10). A transmembrane an-
chored form of FcRIII(CD16) is expressed on NK cells and macrophages, demon-
strating homology in its transmembrane and intracytoplasmic domains to murine
FcR cx. The neutrophil molecule, in contrast, is anchored by a phosphatidylinositol
linkage, yet is nearly identical in sequence to the NK molecule in its extracellular
domains. These differentially anchored molecules respond to the same ligand with
distinctly different responses. ADCC is mediated by the FcRIII(CD16) molecule
on NK cells, yet the neutrophil receptor is unable to mediate this response indepen-
dently (11-13). In contrast, the structural diversity of human FcRII(CD32) has been
largely underestimated. Previous reports have described the isolation of one com-
plete cDNA clone (referred to here as FcRIIa) and a partial clone derived from a
second gene (14-16). Paradoxically, evolutionary conservation of human homologues
for the murine a molecules appeared to be absent based on those reports. In this
study we describe the characterization of multiple cDNA clones for FcRII(CD32)
that arise from three distinct genes. One group of clones correspond to transcripts
derived from a human homologue ofa0 gene, here referred to as FcyRIIb, demon-
strating conservation in sequence, alternative splicing pattern and tissue distribu-
tion to its murine counterpart. Another clone is derived from a gene referred to
as FcyRIIa, which represents a chimera of a and a sequences, while a third
FcyRII(CD32) gene and its corresponding transcript, referred to as FcyRIIa, has
structural features of both FcyRIIa and IIb. The FcyRIIa and IIb molecules can
be transfected into heterologous cells and express low affinity IgG binding mole-
cules. Both the IIa and IIb gene products are recognized by mAbs ofthe CD32 cluster.
Materials and Methods
cDNA Isolation and Characterization.
￿
Human genomic FcyRII DNA fragments were iso-
lated by screeningahuman genomic library constructed by partial Mbo I digestion ofhuman
placenta DNA and ligated into the X phage vector CH28. 500,000 plaques were screened
with a nick-translated 1.3-kb Pst I fragment containing the murine 01 FcyR cDNA insert
(4) at reduced stringency (25% formamide, 5 x SSC, 7 mM Tris, pH 7.5, 10% dextran sul-
fate, and 25 lag/ml sheared salmon sperm DNA at 42'C). Two positive clones were identified,
plaque purified, and further characterized by restriction mapping. A 1.3-kb Bgl II fragment
was identified by its hybridization to the murine (31 cDNA and further analyzed by DNA
sequence analysis. Two exons were found on that fragment that had 60% amino acid ho-
mology to the second extracellular and transmembrane domains of the murine 01 FcyR.
Thus, by virtue of its homologous sequence and genomic organization, this 1.3-kb Bgl II
fragment was determined to encode a human FcyRII gene fragment. This genomic fragment
was used to isolate FcyRIIa from a Xgt 10 cDNA library (kindly provided by Drs. Xue-Dong
Fan and B. Bloom, Albert Einstein College of Medicine, New York, NY) made from poly(A)'
RNA isolated from the human monocyte-like U937 cell line (17). FcyRIIbl and IIb2 were
isolated from a Agt 10 cDNA library (kindly provided by Drs. A. Corbi and T. Springer,
Center for Blood Research, Boston, MA) made from poly(A)' RNA isolated from PMA-
treated HL-60 cells (18). FcyRIb3 and the truncated FcyRIIb clone were isolated from a
Xgt 10 cDNA library (kindly provided by Drs.J. DiSanto and N. Flomenberg, Sloan-Kettering
Institute, New York, NY) made from Daudi poly(A)' RNA. FcyRIIb cDNAs were isolated
using a radiolabeled overlapping oligonucleotide probe based on the previously publishedBROOKS ET AL.
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signal sequence of a partial IIb clone (16). FcyRIIa was isolated from a genomic cosmid li-
braryby screening with mixed FcyRIIa and FcyIIb probes. Its corresponding transcript was
isolated by reverse transcription followed by PCR amplification of neutrophil, monocyte, and
lymphocyte RNA with oligonucleotide probes specific to the IIb 5' untranslated sequences
and Hacytoplasmic sequences. All cDNA library screening was done as previously described
(4). For DNA sequencingcDNA inserts were subcloned into pUC-9 and both strands were
sequenced by the chain termination method (19).
Characterization ofCellular RNA.
￿
RNA isolation, poly(A) selection, and Northern blot anal-
ysis were performed as previously described (4). In brief, RNA (2 jig poly(A)' RNA per
sample in Fig. 6, 10 lcg totalRNA from primary cells) was fractionated on a 2.2 M formalde-
hyde-1 % agarose gel and transferred to nitrocellulose. The filter was hybridized at high strin-
gency (50% formamide, 42 °C) to probes consisting of overlapping oligonucleotides synthe-
sized to the divergent signal sequences of each gene. Specific activities of 10' cpm/pg were
obtained by labeling with a-[32P]dCTP and Escherichia coli polymerase (Klenow fragment).
Rehybridization of filters involved the removal of previously hybridized probe by heating
at 65°C for 1 h in 50 mM Tris, pH 8.0, 2 mM EDTA, 1 x Denhardt's, and 0.5% sodium
pyrophosphate.
For analysis ofcellular RNA by the polymerase chain reaction (PCR), 10 jig of total RNA
was reverse transcribed into cDNA and amplified as previously described (10) with the fol-
lowing modifications. Oligonucleotides were made as described (10) to sequences in the 5'
untranslated region or signal sequence and cytoplasmic domain or 3' untranslated region
that allowed specific hybridization at an annealing temperature of 50°C . Aliquots of each
amplification reaction were fractionated on agarose gels and subjected to Southern blot anal-
ysis as previously described (4). Overlapping oligonucleotide probes made to distinct do-
mains ofFcyRII sequences were labeled and hybridized as above to determine the structure
of these PCR amplified cDNAs.
Cell Culture.
￿
Cell lines HL-60, U937, THP-1, and MOLT-4 were from American Type
Culture Collection (Rockville, MD). K562 was provided by Dr. R. Knowles; AW Ramos,
Daudi, and Raji were provided by Dr. J. Lee; IM-9 was provided by Dr. O. Rosen; and Ltk-
cells were from Dr. N. Flomenberg all of Sloan-Kettering Institute (New York, New York).
K562, HL-60, U937, IM-9, and Ltk- cells were maintained in a-modified MEM sup-
plemented with 10% FCS (Gibco Laboratories, Grand Island, NY) heat inactivated at 56°C
for 30 min, 100 U/ml penicillin, and 100 pg/ml streptomycin. Daudi, Raji, AW Ramos, and
MOLT-4 were maintained in RPMI 1640 supplemented with 25 mM Hepes, pH 7 .4, FCS,
and antibiotics as above. THP-1 was grown in the same RPMI with 5 x 10-5 M /3-mercap-
toethanol.
Primary cells including human monocytes, neutrophils, and NK cells were prepared as
previously described (10). B lymphocytes were prepared from a single human spleen by
separating nonadherent mononuclear cells by Ficoll centrifugation and adhering to plastic
twice (45 min, 37°C). B lymphocytes were purified by negative selection using antiglobulin
rosetting with a mixture of mAbs (CD16, CD56, CD3, CD14, CD5) to deplete T and NK
cells. Populations were >95% purity by indirect immunofluorescence flow cytometry. Human
term placenta was from a spontaneous vaginal delivery and immediately washed in PBS and
frozen in liquid nitrogen.
Gene Transfer andRosettingAssays.
￿
Coding sequences ofall FcyRII cDNAs were cloned into
the Sma I site of the eukaryotic expression vector pCEXV3 . Transient and stable transfec-
tion and rosetting were done as previously described (7). In brief, murine Ltk- cells were
incubated with FcyRII/pCEXV3 plasmid and DEAE-dextran for 16 h, washed, and allowed
to grow for 2 d before rosetting. Transfectants were assayed for rosette formation with TNP
haptenated SRBCs opsonized with anti-DNP murine IgGl mAb (U-7-6; kindly provided
by Dr. Zelig Eschar, Weizman Institute, Rehovot, Israel). Stable transfectants were gener-
ated by calcium phosphate co-transfection with neomycin resistance conferring plasmid
pGCcos3neo and selection with Geneticin (G418; Gibco Laboratories) as previously described
(7). Stable transfectants were selected by rosette formation with murine IgG1 opsonized SRBCs
(above) orwith murine anti-FcyRII mAbs followed by SRBC conjugated with goat anti-mouse
IgG Abs.1372
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m4bs and Indirect Immunofluorescence.
￿
mAbs used in this study were IV.3 (20), KuFc79 (21),
and those of the CD32 cluster (22) including CIKM5, 2A1, KB61, and 41H16. 5 x 105 stable
transfectant cells were incubated with 1 :500 dilutions of ascites for 45 min at 4°C. Cells were
then washed in PBS with 2% FCS and 0.05% sodium azide three times at 40C. Affinity-
purified, FITC-conjugated goat anti-mouse IgG (Boehringer Mannheim Biochemicals, In-
dianapolis, IN) was added to washed cells at 10 Ag/ml and incubated at 4°C for 45 min.
Cells were washed as above and fixed in PBS/1 % formaldehyde. The samples were analyzed
on a Becton Dickinson FACScan 1 cytofluorometer using a Consort 30 data analysis program.
Results
Isolation of cDNA Clones for TcRII(CD32).
￿
The structural homology of human
FcRII(CD32) proteins to their murine counterparts was apparent in their ligand
binding specificity for both murine and human IgG, their tissue distribution and
apparent molecular mass. This structural relationship was exploited in the isolation
ofhuman cDNA clones for this receptor class. DNA probes derived from the murine
a and /3 cDNA sequences were used to screen human genomic libraries at reduced
stringency, resulting in the isolation of genomic clones that, as shown by sequence
analysis, demonstrated 60% sequence identity in the exons encoding the extracel-
lular domains to their murine homologues (not shown). Probes derived from these
exons were used to screen cDNA libraries constructed from RNA derived from he-
matopoietic cell lines that were positive for FcRII(CD32), as determined by their
reactivity with mAbs specific for this receptor. The monocytic line U93 7, the promye-
locytic line HL-60 (differentiated with PMA to macrophage-like cells) and the B
lymphoid line Daudi were screened with these presumptive FcRII(CD32) probes
and positive clones were characterized by DNA sequence analysis. A schematic
representation of these clones is shown in Fig. 1 . Three classes of clones were ob-
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FIGURE 1. Structure of hu-
man FcyRII transcripts and
partial restriction mapof their
respective cDNAs. Five cDNAs
derived from threegenesdesig-
nated IIa, IIa, and IIb have
been identified. FcyRIIb1-3 are
alternatively splicedtranscripts
oftheb gene. Untranslated se-
quences areindicated by aline
and coding sequences by rec-
tangles. The broken edge in
FcyRIIbl indicates an incom-
pletecoding region. The signal
sequences(S), extracellulardo-
mains (EC), transmembrane
domain (TM), andcytoplasmic
(C) regions are indicated. Re-
gionsof >90% nucleotide iden-
tity are indicated by common
crosshatching, open areas, or
stippling. Representative re-
strictionsitesare shown. Num-
bers below a box indicate the
exon organization in alterna-
tively spliced regions. Consen-
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shown andpoly(A)tails arein-
dicated as An.-35
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tained, designated IIa, IId, and IIb. As will be described below, while these clones
demonstrate nearly identical extracellular and transmembrarie domains they differ
considerably in the intracytoplasmic regions (IIa/a vs. IIb) predicted by these se-
quences. In addition, three distinct IIb clones have been isolated that are the result
ofalternative RNA splicing ofboth N112-terminal and COOH-terminal encoding
exons.
Isolation andSequence Analysis ofHumanFeRILa cDNA.
￿
A U937 cDNA library was
screened with the genomic FcyRII probe described above. Two positive phage were
plaque purified and found tobe identical by DNAsequence analysis. The complete
nucleotide and predicted amino acid sequence ofthose FcyRIIa clones are shown
in Fig. 2. An openreadingframe of951 nucleotides, beginningatposition 8, predicts
a mature FcyRIIa protein of 282 amino acids of molecular mass of 31,276 daltons
FIGURE 2.
￿
Thetranslated sequence ofFcyRIIa is presented in one letter code above the nucleo-
tide sequence, which is numbered at the right. A 35 amino acid signal sequence is predicted
and numbered -35 to -1 with an overlined hydrophobic core. Cysteine residues predicted to
form disulfide bridges are circled and N-linked glycosylation sites are boxed. A hydrophobic stretch
of 24 amino acids presumed to span the membrane is overlined. An asterisk denotes the stop
codon and two consensus polyadenylation sites are underlined.1374
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that is identicalto that reported previously (14-16). Theextracellularregion is divided
into two domains, each of which has homology to the Ig C2 set that centers around
two highly conserved cysteine residues. Each extracellular domain retains one of
the two sitesfor N-linked glycosylation that are found in the murine FcyRs to which
this clone is homologous (discussed in detail below). A 28 amino acid hydrophobic
transmembrane domain is followed by a 76 amino acid intracellular region. The
3' untranslated region of FcyRIIa contains two consensus polyadenylation signals
at positions 1352 and 2356 (underlined in Fig. 2). The presence of a stretch of A
residues that arenot encodedin genomic DNA downstream of the second AATAAA
indicates that this clone was derived from a mRNA that was poiyadenylated just
after this site.
Isolation and Analysts of FcyRIIb cDAAs.
￿
The isolation of FcyRIIb cDNAs was
achieved by screening Xgt10 cDNA libraries made from the B cell line Daudi and
amacrophage-like cell line obtained by phorbolester-induced differentiation ofHL-60
cells. Multiple clones were isolated from each library and subjected to restriction
mapping, which revealed four unique groups of cDNAs. Representatives of each
group were purified and their cDNA insertswere subjected to DNA sequence anal-
ysis. These clones are shownschematicallyin Fig. 1; DNA sequencesof three cDNAs
with unique coding regions are shown in Fig. 3. A fourth incompletely processed
cDNA is discussed below. The 1.5-kb FcyRIIb2 cDNA (Fig. 1) contains an open
reading frame beginning at position 81 (Fig. 3) that predicts a protein of 247 amino
acids (Fig. 4). A 44 amino acid signal sequence is predicted to be removed from
this precursor generating a mature protein of 27,178 daltons. The extracellular do-
mains of this protein and FcyRIIa are highly related, having 96% amino acid iden-
tity. This identity includes the four cysteines (circled in Fig. 4) that are predicted
to form two disulfide-bridged Ig-like domains. FcyRIIb2 predicts three N-linked
glycosylation sites in the extracellularregion. The predicted transmembrane anchor
contains a hydrophobic core of 23 amino acids followed by a basic stop transfer se-
quence arg-lys-lys-arg. A 44 amino acid intracellular region, largely unrelated to
FcyRIIa, predicted by this cDNA is particularly rich in acidic residues (23%, Fig.
4). The FcyRIIb2 cDNA has a 3' untranslated region of 487 residues that ends one
nucleotide after the poly(A) addition signal underlined in Fig. 3.
FcyRIIbl is a cDNA sequence of 1,417 nucleotides that is incomplete in that it
lacks sequences predicting the NH2-terminal 19 amino acids of signal sequence
foundin FcyRIIb2. However, genomic DNAsequence analysis indicatesthat FcyRIIbl
begins in the middle of an exon that encodes signal sequences in all other FcyRIIb
cDNAs(Qiu, W Q, andJ. V. Ravetch, unpublishedobservations). It is likely, there-
fore, that this clonewas truncated during construction ofthecDNA library. FcyRIIbl
is identical to IIb2 from positions 139 through 840 (Fig. 3), which corresponds to
sequences encoding the extracellular, transmembrane, and the beginning of the in-
tracellular region. At that position a 57 nucleotide insertion is foundin the FcyRIIbl
cDNA after which the two sequences are once again identical through the end of
the coding regions. This insertion maintains the open reading frame and is known
from genomic cloning to correspond precisely to an exon. These observations, to-
gether with the fact that a 74% amino acid identity to murine FcyR at exists be-
tween these sequences, support identification of this insertion as an alternatively
spliced "on. To confirm the existence of these two (FcyRIIbl and IIb2) alterna-BROOKS ET AL .
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fcrllbl catcaaggctcttccgttccacatccacacagccaatccaattaatcaaaccactgttattaaca 1300
fCrIIb3
fcrIIb2
fcrIIbl gataatagcaacttqggaaatgcttatgttacagqttaccgttqagaacaatcatctaaatctat 1365
fcrIIb3
fcrIIb2
fcrIIbl atgatttcagaaatgttaaaatagactaacctctaccagcacattaaaagtgattgtttctggqt 1430
fcrIIb3
fcrIIb2 "" """""ttattgatgatttttattttctttatttttctataaagatcatatattacttttata 1495
fcrIIbl gataaaaaaaaaaaaaaaaaaaaaaa
fcrIIb2 aaaa 1500
FIGURE 3 .
￿
Nucleotide sequences ofthree alternatively spliced forms ofFcyRIlbcDNAs . Numbers
in the right hand margin are arbitrary in that they denote positions in the composite sequence
only and do not correspond to a particular cDNA. Untranslated regions are indicated in lower
case while coding regions areshown in upper case. Asterisks indicate identitywith the nucleotide
below, whilehyphens indicate the absence of a nucleotide in an alternatively spliced exon . The
consensus polyadenylation site is underlined . These sequence data have been submitted to the
EMBL/GenBank Data Libraries .
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fcrIib3 "
￿
------
fcrIlb2 NGIISFLPVUTESDWADC """""""+""""""*+" """""*" +** ., .*+.******* . ...* .
fcrllbl
￿
KSPQPWGFDQ.LWTAVLFLAPVAG TPAAPPKAVLKLEPQWINVLQED 21
.1
fcrIIb3
fcrIIb2
fcrIlbl SVTLIOGTHSPFSDSIQWFHNGNLIPTHTQPSYRFKANI
￿
EY
￿
ISISDPVHLTVLS 86
fcrIIb3
fcrIIb2 +"**.*..+,.*.++
￿
*+ .++
fcrIIbl EWLVIATPHLEFQEGETIVIdOISWKDKPLVKVTFFQNGKSKKFSRSDl1E PQA NI~iSGDYH 151
fcrIIb3 "
￿
**** ..
fcrIlbl ~'GNIGYTLFSSKPVTITVQAPSSSPMGIIYAVVTGIAVMIVAAWALIYCRKKRISALPGYPE 216
fcrIIb3 " "+ "" """"
fcrIlb2 --- __---___
￿
"** .***+* .+*****++,
fcrIIbl CREHGETLPEKPANPTNPDEADKVGAENTITYSLIIIHPDALEEPDDQNRI
￿
266
FIGURE 4.
￿
Amino acid sequences predicted by the three alternativelyspliced forms of FcyRIIb
cDNAs are presentedin theone letter code. Numbers in the right hand margin denote amino
acid positions of FcyRIIbl. Asterisks indicate identity with the amino acid below andhyphens
indicate amissing residue from an alternatively spliced exon. A 44 amino acid signal sequence
with an underlined hydrophobic core is predictedprecedingposition +1. Cysteine residues that
are predicted to form disulfidebondsarecircled. Sites for N-linked glycosylation areboxed. The
23 amino acid hydrophobic core of the transmembrane domain is underlined.
tively spliced messages in authentic cellular RNA, FcyRIIb-specific oligonucleotide
primers were annealed to RNA extracted from myeloid and lymphoid cells, con-
verted to cDNAby reversetranscription andtheresulting DNA standwas amplified
by the PCR. Sequence analysis ofthese cDNAs confirmed the existence ofalterna-
tively spliced messages that correspond preciselyto FcyRIIbl and IIb2 (not shown).
FcyRIIbl ends with 19 A residues that are notencoded in the known FcyRIIb gene.
This sequence presumably represents a poly(A) tail in the mRNA that gave rise
to this clone, although no consensus polyadenylation signal is found in preceding
sequences (discussed below).
The cDNA termed FcyRIIb3 in Figs. 1 and 3 contains an open reading frame
of931 nucleotides beginning at position 81 that predicts a mature protein of29,277
daltons (like FcyRIIbl). The feature that distinguishes FcyRIIb3 from previously
discussed cDNAs ofthis subclass is the deletion of 21 nucleotides (193-213 in Fig.
3) that predict the last seven amino acids ofthe signal sequence (Fig. 4). Genomic
sequence analysis indicates that the missing nucleotides correspond precisely to an
exon that is located between exons encoding the NH2-terminal sequences of the
signal sequence and the first extracellular domain, suggesting that this difference
results from an alternative splicing event. It should be noted that the exon that is
spliced out in FcyRIIb3 encodes amino acids contributing to the hydrophobic core
of the signal sequence ofa nascent FcyRIIb protein (Fig. 4). A similar situation
has been described for transcripts of the ct subunit gene ofthe rat high affinity IgE
receptor. A 21-bp exon encoding the COOH-terminal sequences of the signal se-
quence undergoes alternative splicing, as defined by cDNA analysis of mast cell
RNA (23).
These studies demonstrate that primary transcripts from the FcyRIIb gene un-
dergo alternative splicing at both the 5' end to generate FcyRIIb3 and at the 3' end
togenerate the alternative cytoplasmic domains exemplified by FcyRIIbl and IIb2.
In addition to these clones containing complete coding sequences, we have iso-
lated atruncated FcyRIIb cDNA that lacks sequences encoding thecytoplasmicre-
gion of these receptors. This truncated clone is identical to FcyRIIb2 from the 5'
untranslated region through sequences predicting the transmembrane domain (po-BROOKS ET AL.
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sitions 67-840 in Fig. 3) at which point it diverges completely. The divergent se-
quence is identical to that of the genomic intron of this region and to that of the
previously isolated cDNA of this subclass (16), suggesting that both cDNAs repre-
sent incompletely processed pre mRNAs.
Isolation andAnalysis ofFcyRIIa'.
￿
A minimumof threedistinct genes encode FcyRII
transcripts. Overlapping cosmid clones encoding human FcyRII genes have been
isolated and analyzed. The sequence of those clones confirms that Fc'YRIIa derives
from one gene and that the FcyRIlb sequences (1, 2, and 3) are derived from alter-
native splicing of a second gene (Qiu, W. Q, andJ. V. Ravetch, unpublished obser-
vations). A third FcyRII gene was identified that is composed of the 5' exons of an
FcyRIlb-like gene (5' untranslated, signal, extracellular, and transmembrane) and
the3' exonsofan FcyRIIa-like gene (cytoplasmic and3' untranslated; Qiu, WQ, and
J. V. Ravetch, unpublished observations). This gene is predicted to give rise to tran-
scripts that are structurally distinct from the FcyRIIa and IIb molecules discussed
above. A cDNA clone was isolated from a Daudi library and characterized. Its se-
quence indicated that it represented an incompletely processedtranscript ofthis IIa'
gene, lacking only the last cytoplasmic and 3' untranslated sequences. To test for
the presence of a complete transcript, cellular RNAs were characterized by reverse
transcription and PCRamplification using a 3' cytoplasmic domain oligonucleotide
from FcyRIIa and a 5' untranslated region oligonucleotide from FcyRIlb. AcDNA
productof theexpected size andstructurewasobtained (Fig. 1) in neutrophil mono-
cytic and B lymphoid cell RNAs as confirmed by hybridization to domain specific
probes (data not shown). The sequence of IIa' is >99% identical to IIb from the
5' untranslated through the transmembrane domain. The cytoplasmic and 3' un-
translated sequences, however, are >95% identical to IIa (data not shown).
Sequence Homology between Murine andHumanFcyRIIs.
￿
Comparisons ofhuman and
mouse FcyRII cDNAs shown in Fig. 5 (nucleotide) and Table I (amino acid) reveal
both striking homology and significant differences. Dot matrix comparison of the
human FcyRIIb2 cDNA sequence with that of its murine homologue (Fc,YRa2)
shows that they are related throughout their length, as shown in Fig. 5 D. From
a high of 75% in the extracellular region, these sequences retain >50% nucleotide
identity in 5' and 3' noncoding regions. In a similar fashion, comparison of human
FcyRIIbl with its murine homologue FcyR (3, shows the close relationship between
these gene products. However, a deletion of 81 nucleotides in the cytoplasmic do-
main of FcyRIIbl is apparent relative to its murine counterpart (Fig. 5 C). In con-
trast, comparison ofhuman FcyRIIa and murine FcyR cx (Fig. 5 B, Table I) reveals
a markedly different pattern. Those transcripts demonstrate homology in nucleo-
tide sequences predicting the signal sequence and extracellular domains. However,
the transmembrane, cytoplasmic, and 3' untranslated regions of these two clones
share no homology.
The evolutionary relationship of FcyRIIa/d with its murine counterpart is evi-
dent from the two regions of homology that are found between human FcyRIIa/a
and IIb(ormurine /3, not shown) (Fig. 5A). The first region begins with nucleotide
sequencesthat predict the extracellular region and continuesthrough the membrane
spanning domain and into the first portion of the cytoplasmic region (Table I). A
1-kb insertion follows in theFc7RIIaJa' sequence forwhichno homology in FcyRIIb
is apparent. The second homology region begins in the 3' noncoding region of1378
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huFcRIIa
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hu FcRIIbl
￿
huFcRIIb2
3'WT
FIGURE 5.
￿
Dot matrix comparison of FcyR cDNA sequences of human and mouse using the
DIAGON program (24). Complete nucleotide sequences ofhuman (hu; this article) and murine
(mu, reference 4) FcyRs are compared along the x- ory-axis as indicated. The 5' untranslated
(5'), signal sequence (S), extracellular (EC), transmembrane (TM), cytoplasmic (C), and Tun-
translated regions are indicated in letters and demarcated by horizontal and vertical solid lines.
Regions of nucleotide identity appear as dots and diagonal lines. Insertions of nucleotide se-
quence appear as gaps in the diagonal line. Full size scale bars denote spacing of 100 base pairs
on all axes. (A) Comparison of human FcyRIIa and IIbl cDNAs. (B) Comparison of human
FcyRIIa and murine FcyR a. (C) Comparison of human FcyRIIbl and murine FcyR 01. (D)
Comparison of human FcyRIIb2 and murine FcyR 02.
Amino Acid Sequence Homology Between Human and Mouse FcyRII
huFcyRIIa cytoplasmic domain is encoded by 2 exons, the shorter NH2-ter-
minal exon is 60% identical to huFcyRIIb2 and 37°ío identical to moFCYRß2.
The longer COOH-terminal region is unrelated to either ofthese cDNAs result-
ing in a nonsignificant overall homology.
Fc,yR S EC TM C
0 /0
IIa:IIb2 17 96 88 <15"
IIa:a 55 59 <15 <15
IIa:02 23 61 50 <15`
Ilb:a <15 60 <15 <15
IIb1:0 1 48 63 64 60
IIb2:02 48 63 64 53
a:,ß <15 95 <15 <15BROOKS ET AL.
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FcyRIIa/a' and in sequences encoding the cytoplasmic domain ofFcyRIIb2 and ex-
tendsthroughtheendofboth clones (Fig. 5A, see Discussion) . In view of the extern
sive homology between FcyRIIb2 and its murine homologue 02 (Fig . 5D) the latter
cDNA also shares a strong homology with the 3' untranslated region of FcyRIIa/a.
FcyRIIa, though not IIa, has a chimeric organization, with distinct regions that
are homologous to either of the two murine FcyRs . The FcyRIIa signal sequence
is homologous only to the murine ci FcyR (Fig. 5 B), with both IIa and IIa'demon-
strating homology in their extracellular region to both murine a and (3 sequences,
while their transmembrane, some of the cytoplasmic and 3' untranslated regions
are homologous to the murine (32 FcyR or its human homologue FcyRIIb2 (Table
I and Fig . 5 A) .
FcyRs Display Distinct Patterns ofmRNA Expression.
￿
To determine if these structur-
ally distinct molecules displayed different patterns ofmRNA expression, as in the
mouse (4), oligonucleotide probes to the signal sequences ofFcyRIIa and IIb were
used to reveal distinct patterns ofmRNA expression by Northern analysis . FcyRIIa
transcripts are expressed in monocyte-like cell lines (Fig . 6 A, lanes 3-7), HL-60
differentiated with DMSO (Fig. 6 A, lane 2), and in the erythroleukemic cell line
K562 (Fig. 6 A, lane 1) . Four lymphoid cell lines do not express FcyRIIa mRNA
(Fig . 6A lanes 9-12) although the Burkitt lymphoma cell line Daudi does (Fig . 6
FIGURE 6.
￿
Northern blot analysis of human FcyRII RNAexpression . 2 wg of poly(A)+ RNA
was prepared from human cell lines described in Materials and Methods and electrophoresed
in a formaldehyde agarose gel and transferred to nitrocellulose. (A) The filter was hybridized
with aFcyRIIasignal probe indicated schematically below the autoradiogram . (B) After removal
ofthe probe andpreexposure the filter was rehybridized to aFcyRIIb signal probe as indicated.
RNAconcentration wasnormalized by ethidium bromide stainingand hybridization with actin .1380
￿
SEQUENCE HETEROGENEITY OF HUMAN FcyRII (CD32)
A, lane 8). As shown in Fig. 6 A, the human FcyRIIa-specific signal probe reveals
two bands of 2.6 and 1.5 kb in all positive cell lines. A cDNA probe to sequences
3' ofthe first polyadenylation signal ofFcyRIIa (see Figs. 1 and 2) hybridized only
to the 2.6-kb transcript (data not shown), suggesting that thesetwo transcripts arise
from differential polyadenylation . In contrast to IIa, the FcyRIIb signal probe de-
tects a band of 1.5-1.6 kb that is expressed in numerous lymphoid and myeloid cell
lines as shown in Fig. 6 B (lanes 3-11). Amongcell lines that have been tested, only
K562 (lane 1), MOLT-4 (lane 12), and DMSO-treated HL-60 (lane 2) do not ex-
press FcyRIIb mRNA. However, the IIb signal probe cannot distinguish between
IIa and IIb since the predicted FcyRIIa transcript, identified in neutrophils, mono-
cytes, andlymphocytes, possessesaFcyRIIb-like signal. These transcriptscan, however,
be distinguished using PCR and distinct combinations of oligonucleotides as de-
scribed above (Materials and Methods). In this manner, IIa' expression has been
detected in neutrophils, B lymphocytes, cultured adherent monocytes, U937 cells,
and placenta, but not in T lymphoid cell line RNAs (data not shown). To confirm
results obtainedwith celllinestotal RNAs from primary human cells were analyzed
for FcyRII expression (not shown). Neutrophils, cultured adherent monocytes, and
chronic myelogenous leukemia cells all expressed abundant FcyRIIa mRNA by
Northern analysis. Human placenta, a rich source of monocyte and macrophage-
like cells, expressed readily detectable FcyRIIa and IIb mRNA on Northern blots.
In contrast FcyRIIb mRNA could only be detected in B lymphocytes, cultured ad-
hert monocytes, and neutrophils by reverse transcription and PCR amplification
of these primary cell RNAs.
Immune ComplexesofIgGandmAbs BindHumanFcyRIIExpressedby Gene Transfer.
￿
The
ligand binding properties and epitopes ofFcyRII proteins predicted by thesecDNAs
were determined by the expression of these clones in FcyR- fibroblast cells. Tran-
sient transfection of murine Ltk- fibroblasts with FcyRII cDNAs cloned into an
SV40-based vector (pCEXV3) resulted in cell surface expression ofall FcyRs dis-
cussed above. Positive transfectants were detected by binding of mouse IgGI op-
sonized SRBCs indicatingthe capacity ofthese FcyRs to bind multivalent immune
complexes (Fig. 7). FcyRIIa (Fig. 7 A) demonstrates a consistently decreased level
ofmouse IgG1 rosetting. This difference is not due to a difference in the efficiency
ofcell surface expression ofthe protein encoded by this cDNA, since rosetting with
mAb IV.3 (20)-coupled erythrocytes gave equivalent densities of bound cells (not
shown). Rather, these data suggest that FcyRIIa has a decreased affinity for mouse
IgGI compared with FcyRIIb. FcyRIb3, lacking part ofthe hydrophobic core of
its signal sequence, yields transfectants with an equivalent density ofbound mouse
IgGI- or CD32 mAb-coated SRBCs, indicatingthe functional integrity ofthe sur-
face FcyRII molecule. The functional consequences ofthis alternative splice is not
apparent and is under investigation.
Characterization ofthese sequences as encoding authentic FcyRII proteins was
determined byepitope mappingusingwell-characterized mAbs (20-22)that define
this class ofmolecules. Murine fibroblasts stably expressing human FcyRs were as-
sayed by indirect immunofluorescence and flow cytometry for recognition by anti-
FcRII mAbs. All CD32 mAbs (22) and the mAbs IV3 (20) and KuFc79 (21) recog-
nized both FcyRIIa and IIb transfectants (not shown).BROOKS ET AL .
￿
1381
FIGURE 7 .
￿
Rosetting assay ofhuman FcyRII expressing transfected cells. FcR- mouse LTK-
fibroblasts were transiently transfected with the indicated human FcyRIIcDNA in the expres-
sion vector pCEXV3 . 2 d after transfection, positive cells were detected by binding of mouse
IgG1 opsonized SRBCs . Plates were washed of unbound SRBCs, fixed in glutaraldehyde, and
photographed. (a) Ha, (b) IIbl, (c) H62, (d) IIb3 .
Discussion
In this article we establish the structural heterogeneity ofhuman FcyRII mole-
cules . Previous studiesusingIgG affinity bindingand an anti-FcyRIImAb(20) sug-
gested that this class of molecules was more heterogeneous than couldbe accounted
for by the expression pattern of the previously isolated FcyRII cDNA (14-16 ; this
article) . Cloning of multiple cDNAs representing alternatively spliced transcripts
of the FcyRIIb gene and identification of the IIa' transcript complement the previ-
ously isolated cDNA as subclasses of this important class ofreceptors . Overlapping
yet distinct subsets of cell lines expressmRNAs encoding these receptors . This pat-
tern ofRNA expression is consistent with the distribution of FcyRII protein deter-
mined by mAb andligand binding studies . Botha andbsubclasses of FcyRII have
been shownby gene transfer to bindimmune complexes and be recognized by anti-1382
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FcRII mAbs. Together thesethreesubclasses account for all ligand and mAb binding
attributed to human FcRII to date.
Human FcyRIIa, IIa' and IIb cDNAs predict proteins that are closely related yet
have important structural differences. In particular, the mature proteins predicted
by FcyRIIa and IIa genes are >95% identical throughout. Receptors predicted by
the FcyRIIb cDNAs share this homology with IIa/IIa' in the extracellular domain
accounting for their ability to bind common ligands and mAbs. Unlike their murine
counterparts the human receptors display high homology in their transmembrane
domains (Table I). While 10 ofthe first 12 residues of their intracellular regions are
identical, FcyRIIaJa' and IIb2 diverge completely at that point. The largely diver-
gent cytoplasmic tails of these receptors may mediate distinct functions in response
to binding a common ligand.
Both conservation and divergence in primary structure of members of the murine
and human FcyR multigene families lead to important predictions about their func-
tions. A striking conservation of sequence is observed between human FcyRIIb and
murine FcyR a. A human gene encoding FcyRIIb has an identical exon-intron or-
ganization to that ofthe FcyR 0 gene (Qiu, W Q, andJ. V. Ravetch, unpublished
observations). In both species there is alternative splicing of the primary transcripts
from these genes that involves their first cytoplasmic exons. The human FcyRIb2
and murine FcyR /32 cDNAs lacking these exons are homologous throughout their
coding and noncoding regions (Fig. 6 D). In contrast, the cDNA molecules including
these exons reveal an interspecies divergence (Fig. 6 C). In human FcyRIIbl there
is a deletion of sequences corresponding to the COOH-terminal 27 amino acids
of the first cytoplasmic exon of murine FcyR al, a result of the utilization of a
cryptic splice donor site in this sequence. Surprisingly, this same sequence AGGT
GAGT is present in the murine homologue (4), yet its use as a splice donor has
not been detected.
In contrast, a direct relationship between human FcyRIIa, IIa, and a single mu-
rine counterpart is not obvious. Analysis of both cDNA and genomic sequence data
for FcyRIIa and IIa' indicates that the sequence preceding the second region of ho-
mology between FcyRIIa/a and murine FcyR (32 (or human FcyRIIbl, Fig. 5 A)
could be a mutated splice acceptor site. In particular, a T residue inserted into the
critical AG splice acceptor dinucleotide (Fig. 8) would have rendered that site non-
functional. With the utilization of a cryptic splice site in the intron preceding this
site, thesesequences persist as exon in FcyRIIa/a' transcripts. Therefore, the nucleo-
huFcyRIIa
AATAAA AATAAA
S UT TM
c,
Y6NAG
2
TAA
huFcyRIlb
TM C, C2
YAGY7 NATG
Y
UT
AATAAA
101. 010MRMIME
3
FIGURE 8.
￿
Schematic comparison of the 3'
ends ofhuman FcyRII genes. Sequencescon-
tributing to cDNAs reported here are boxed
andlabeled as in Fig. 1. Intron sequences are
indicated by broken horizontal lines. Cross-
hatching andstipplingindicate regionsofhigh
homology. Relevant nucleotide sequencesare
indicatedincluding: polyadenylation signals,
stop cocions, and splice acceptor sites, Y,
pyrimidine; N, anynucleotide. TheTresidue
that is proposed to have mutateda splice ac-
ceptor site in the FcyRIIa gene is shown in
bold. The structure o£ the IIa gene is iden-
tical to Ha in this region.BROOKS ET AL.
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tidesequences forboth coding regionsand3'untranslated sequences ofmurine FcyR
0 and human FcyRIIb (Fig. 5 A) are homologous to the 3' untranslated region of
human FcyRIIa/d because ofthe presence ofthe ancestral cytoplasmic/3' untrans-
lated exon in the latter sequence (Fig. 8). The novel exon found in the FcyRIIa/a'
gene likely results from these events having converted sequences 3' of the new ac-
ceptor site, which are intron sequences in IIb and mouse S, to exon sequences in
IIa/a: Thus, IIa most likely arose from anancestral IIb gene by mutation ofasplice
acceptor site and utilization ofa cryptic site. The persistence ofthose sequences as
an open reading frame for the cytoplasmic domain of the human Ha/a' transcript
suggests the acquisitionofafunctional rolefor these sequences. Thechimeric struc-
ture of FcyRIIa noted above (Fig. 5, A and B) suggested that the transcript from
which this cDNA was obtained istheproduct ofa gene that arose by recombination
between two genes that were precursors of the present day murine Fc'YRa and 0
genes. Such an event would explain the murine FcyR alike signal sequence and
murine FcyR02-(or human Fc7RIb2) like transmembrane, first cytoplasmic por-
tion, and 3' untranslated regions noted above and by others (16).
Selective functions for FcyRs IIa, Ila, and IIb are further suggested by the cell
type-specific expression ofthese three genes. RNA expression from these genes has
been distinguished through useofsignal sequenceprobes thatare specific forFcyRIIa
and FcyRs IIa'/IIb and by the use ofreverse transcription and PCR to distinguish
IIa' from IIb. Monocyte/macrophage-like human cells includingcultured adherent
monocytes and cell lines such as U937 express all three subclasses of FcyRII. Pe-
ripheral blood neutrophils express readily detectable FcyRIIa mRNA with alower
level of FcyRIIb and FcyRIIa' mRNA. Splenic B lymphocytes and cell lines of B
lymphoid origin (IM-9, Daudi, Raji, AW Ramos) all express FcyRIIb mRNA, a
finding that is consistent with the ubiquitous lymphocyte expression ofthe murine
homologue, FcyR a (4). Three human T cell lines (MOLT4, Jurkat, and Fro-2)
fail to express detectable levels ofhuman FcyRII mRNA. While these patterns of
RNA expression are consistent with previous studies of RNA (14-16) and protein
expression (reviewed in references 1 and 9) for FcyRII (CD32), those studies failed
todistinguish betweensubclassesoftheFcyRII(CD32) family asdemonstrated here.
Recognition ofthe structural differences among these molecules and their specificities
ofcellular expression suggest functionally important distinctions.
Summary
The structural heterogeneity of the human low affinity receptor for IgG,
FcRII(CD32), has been elucidated through the isolation, characterization, and ex-
pression ofcDNA clones derived from myeloid and lymphoid RNA. These clones
predict aminoacid sequences consistentwith integralmembrane glycoproteinswith
single membrane spanning domains. The extracellular domains display sequence
homology to other FcyRs and members ofthe Ig supergene family. A minimum
ofthree genes (FcyRIIa, IIa, and FcyRIIb) encode these transcripts, which demon-
strate highly related extracellular and membrane spanning domains. IIa/IIa' differ
substantially in the intracytoplasmic domain from IIb. Alternative splicing of the
IIb gene generates further heterogeneity in both NH2- and COOH-terminal do-
mains of the predicted proteins. Comparison to the murine homologues of these
molecules reveals ahigh degree ofconservation between theproducts ofone ofthese1384
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genes, FcyRIIb, and the murine 0 gene in primary sequence, splicing pattern, and
tissue distribution. In contrast, the sequence ofIIa' indicates its relationship to the
0-like genes, with mutation giving rise to a novel cytoplasmic domain, while IIa
is a chimera ofboth a- and 0-like genes. Expression ofthese cDNA molecules by
transfection results in the appearance of IgG binding molecules that bear the epi-
topes defined by the FcRII(CD32) mAbs previously described.
We thank Dr. Bice Perussia for her assistance with the flow cytometry analysis and for
stimulating discussions. We thank A. Pavlovec andJ. Dadgar for technical assistance and
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Note added in proof: cDNA clones essentially identical to IIa and IIb2 have recently been de-
scribed (25).
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